BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17929104)

  • 1. The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome.
    Shibata C; Funayama Y; Fukushima K; Ueno T; Kohyama A; Satoh K; Shimosegawa T; Yamagiwa T; Sasaki I
    J Gastrointest Surg; 2008 Feb; 12(2):344-9. PubMed ID: 17929104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
    Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
    Mihas AA; Hirschowitz BI; Gibson RG
    Digestion; 1978; 17(1):1-10. PubMed ID: 627316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glucagon on serum gastrin. II. Studies in pernicious anaemia and the Zollinger-Ellison syndrome.
    Korman MG; Soveny C; Hansky J
    Gut; 1973 Jun; 14(6):459-61. PubMed ID: 4719212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations.
    Wolfe MM; Jain DK; Edgerton JR
    Ann Intern Med; 1985 Aug; 103(2):215-7. PubMed ID: 4014903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective intra-arterial methylene blue injection: a novel method of localizing gastrinoma.
    Ko TC; Flisak M; Prinz RA
    Gastroenterology; 1992 Mar; 102(3):1062-4. PubMed ID: 1537497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
    Brady CE
    Am J Gastroenterol; 1991 Feb; 86(2):129-34. PubMed ID: 1992623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
    Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
    J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
    Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
    Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome.
    Thompson JC; Reeder DD; Villar HV; Fender HR
    Surg Gynecol Obstet; 1975 May; 140(5):721-39. PubMed ID: 1145407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.
    Nakanome C; Ishimori A; Goto Y; Yamazaki T; Kameyama J; Sasaki I; Inui M; Furukawa Y; Komatsu K
    Gastroenterol Jpn; 1981; 16(3):213-22. PubMed ID: 6114893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
    Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
    Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome).
    Deveney CW; Deveney KS; Jaffe BM; Jones RS; Way LW
    Ann Intern Med; 1977 Dec; 87(6):680-6. PubMed ID: 931203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Zollinger-Ellison syndrome].
    Becker HD
    Wien Klin Wochenschr; 1984 Feb; 96(4):138-44. PubMed ID: 6324497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet cell tumors and the ulcerogenic syndrome.
    McGuigan JE
    Monogr Pathol; 1980; 21():177-84. PubMed ID: 6261121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrins in Zollinger-Ellison syndrome: identification of localized disease.
    Johnson JA; Fabri PJ; Lott JA
    Clin Chem; 1980 Jun; 26(7):867-70. PubMed ID: 7379308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome.
    Metz DC; Buchanan M; Purich E; Fein S
    Aliment Pharmacol Ther; 2001 May; 15(5):669-76. PubMed ID: 11328261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.